成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information

Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11974
82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

Product List
H-Ile-Lys-Val-Ala-Val-OH 131167-89-0
Concizumab 1312299-39-0
Vofatamab 1312305-12-6
Syk-IN-3 1312534-69-2
Parsatuzumab 1312797-14-0
ABzOH 1313028-09-9
ALM301 1313439-71-2
Pinatuzumab vedotin 1313706-14-7
KAT modulator-1 1314006-43-3
CYM50374 1314212-81-1
Duligotuzumab 1314238-96-4
Orticumab 1314241-10-5
PKR-IN-C51 1314594-23-4
hGPR91 antagonist 3 1314796-31-0
SAR247799 1315311-14-8
Triumbelletin 131559-54-1
GSK854 1316059-00-3
Simtuzumab 1318075-13-6
Endomorphin 1 acetate 1276123-71-7
Cavutilide 1276186-19-6
SRI 6409-94 127697-58-9
Maslimomab 127757-92-0
Lampalizumab 1278466-20-8
dCeMM4 1281683-44-0
Raxofelast 128232-14-4
PLpro/RBD-IN-1 1282451-83-5
Antifolate C2 1286279-90-0
Opc 18750 128667-63-0
20-HETE Intermediate 15 1286736-37-5
HMBR 1287651-36-8
Fallaxsaponin A 1287702-60-6
Tigulixostat 1287766-55-5
LSD1-IN-30 1289575-45-6
LY2881835 1292290-38-0
TRC160334 1293289-69-6
Irtemazole 129369-64-8
Demethylcantharidate disodium 129-67-9
Nesvacumab 1296818-77-3
Minalrestat 129688-50-2
Vorozole 129731-10-8
Inebilizumab 1299440-37-1
Soretolide 130403-08-6
Ampelopsin A 130608-11-6
ML089 1306638-12-9
Nemazoline Free Base 130759-56-7
Lecimibide 130804-35-2
Iothalamate meglumine 13087-53-1
Besipirdine hydrochloride 130953-69-4
Tubulin inhibitor 8 1309925-39-0
Palmatine hydroxide 131-04-4
Futuximab 1310460-85-5
Modotuximab 1310460-86-6
Ozanezumab 1310680-64-8
PFM39 1310744-67-2
Tazomeline 131987-54-7
5-HT6/7 antagonist 1 131999-28-5
Rilmakalim 132014-21-2
(-)-Vorozole 132042-69-4
Dalvastatin 132100-55-1
(E/Z)-Zotiraciclib hydrochloride 1321626-25-8
Bocconoline 1322007-90-8
Ligelizumab 1322627-61-1
Enzaplatovir 1323077-89-9
Vamicamide 132373-81-0
Lesopitron 132449-46-8
Lesopitron HCl 132449-88-8
Aprikalim 132562-26-6
HPPE 1325721-55-8
Rocepafant 132579-32-9
Anifrolumab 1326232-46-5
Tildrakizumab 1326244-10-3
Rucaparib camsylate 1327258-57-0
Butyl chlorogenate 132741-56-1
Cdc7-IN-7c 1330781-04-8
Chloroprocaine 133-16-4
Vinaxanthone 133293-89-7
Sitagliptin fenilalanil hydrochloride 1339954-75-4
PERK-IN-2 1337531-83-5
WY-47766 134217-27-9
Ebaresdax hydrochloride 1334385-87-3
3,5,6-trihydroxysitostane 133697-68-4
5-A-RU hydrochloride 134452-11-2
Compound 10w 1336890-05-1
EBOV-IN-1 1335113-30-8
Quilseconazole 1340593-70-5
Safironil 134377-69-8
MK 0434 134067-56-4
ML372 1331745-61-9
(Iso)-Samixogrel 133276-52-5
Seribantumab 1334296-12-6
Upacicalcet 1333218-50-0
IMSs inhibitor S12 Perchlorate 1334529-08-6
MK-8325 1334314-19-0
Abrilumab 1342290-43-0
BW-1370U87 134476-36-1
PLH1215 1332084-64-6
PERK-IN-6 1337532-14-5
(Rac)-Sabcomeline HCl 133642-67-8
Imifoplatin 1339960-28-9
Sitagliptin fenilalanil 1339955-03-1
82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

Copyright 2007©  ChemicalBook. All rights reserved.